AMGN

AMGEN Inc

Oct 17 • 04:00PM ET

298.81

+3.00 1.01 %

Healthcare • Drug Manufacturers - General • USA • NASD

Peers: BIIB GILD REGN VRTX BMY MRNA ILMN PFE NBIX ABBV

| Held by: VTI VOO QQQ SCHD IVV SPY DIA VTV XLV VIG

Index	DJIA, NDX, S&P 500	P/E	24.45	EPS (ttm)	12.22	Insider Own	0.20%	Shs Outstand	538.30M	Perf Week	2.99%
Market Cap	160.87B	Forward P/E	13.82	EPS next Y	21.62	Insider Trans	-0.35%	Shs Float	537.30M	Perf Month	8.33%
Enterprise Value	209.04B	PEG	5.82	EPS next Q	5.04	Inst Own	81.96%	Short Float	2.40%	Perf Quarter	0.99%
Income	6.62B	P/S	4.63	EPS this Y	6.34%	Inst Trans	0.29%	Short Ratio	5.68	Perf Half Y	7.76%
Sales	34.76B	P/B	21.65	EPS next Y	2.47%	ROA	7.40%	Short Interest	12.91M	Perf YTD	14.64%
Book/sh	13.80	P/C	20.04	EPS next 5Y	4.20%	ROE	99.14%	52W High	335.88 -11.04%	Perf Year	-8.08%
Cash/sh	14.91	P/FCF	15.17	EPS past 3/5Y	-9.75% -10.10%	ROIC	10.82%	52W Low	253.30 17.97%	Perf 3Y	21.25%
Dividend Est.	9.62 (3.22%)	EV/EBITDA	13.73	Sales past 3/5Y	8.54% 7.40%	Gross Margin	68.86%	Volatility	2.22% 2.43%	Perf 5Y	24.76%
Dividend TTM	9.39 (3.14%)	EV/Sales	6.01	EPS Y/Y TTM	110.67%	Oper. Margin	27.90%	ATR (14)	6.45	Perf 10Y	99.75%
Dividend Ex-Date	Aug 22, 2025	Quick Ratio	0.98	Sales Y/Y TTM	13.10%	Profit Margin	19.04%	RSI (14)	60.54	Recom	2.39
Dividend Gr. 3/5Y	8.53% 9.18%	Current Ratio	1.31	EPS Q/Q	91.96%	SMA20	3.14%	Beta	0.43	Target Price	311.12
Payout	119.05%	Debt/Eq	7.57	Sales Q/Q	10.01%	SMA50	4.06%	Rel Volume	0.85	Prev Close	295.81
Employees	28000	LT Debt/Eq	7.24	Earnings	Nov 04 AMC	SMA200	3.14%	Avg Volume	2.27M	Price	298.81
IPO	Jun 17, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	13.98% 2.72%	Trades		Volume	1,930,553	Change	1.01%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-03-25	Resumed	Raymond James	Mkt Perform
May-20-25	Resumed	Guggenheim	Neutral	$288
Apr-22-25	Resumed	Cantor Fitzgerald	Neutral	$305
Dec-10-24	Resumed	BofA Securities	Underperform	$256
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270

Show Previous Ratings

Oct-17-25 04:00PM	FDA APPROVES TEZSPIRE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (PR Newswire)
06:22AM	The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics (Zacks)
Oct-16-25 09:31AM	How Will Mounjaro and Zepbound Sales Aid Lilly's Upcoming Q3 Results? (Zacks)
01:59AM	Oppenheimer Highlights Amgen's (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study (Insider Monkey)
Oct-15-25 05:50PM	Amgen (AMGN) Laps the Stock Market: Here's Why (Zacks)
01:06PM	Loading…
Oct-14-25 01:06PM	Amgen (AMGN) Announces Launch of AmgenNow (Insider Monkey)
12:00PM	JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit (Zacks)
Oct-13-25 12:10PM	Why Amgen (AMGN) Could Beat Earnings Estimates Again (Zacks)
08:43AM	Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention (Insider Monkey)
Oct-12-25 11:32PM	Reflecting On Therapeutics Stocks' Q2 Earnings: Amgen (NASDAQ:AMGN) (StockStory)
Oct-10-25 12:10PM	Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know (Zacks)
04:41AM	Here's What to Expect From Amgens Next Earnings Report (Barchart)
Oct-09-25 11:55AM	What Do Charts Say About the Dow? 3 Favorite Stocks That Could Lead a Year-End Push (Barrons.com)
11:00AM	Is Novo Nordisk Stock a Sell Despite its 10% Price Rally in a Month? (Zacks)
Oct-08-25 09:00AM	Is Trending Stock Amgen Inc. (AMGN) a Buy Now? (Zacks)
12:35AM	Loading…
12:35AM	2 S&P 500 Stocks to Target This Week and 1 Facing Challenges (StockStory)
Oct-07-25 01:45PM	Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60% (Zacks)
Oct-06-25 05:50PM	Amgen (AMGN) Stock Sinks As Market Gains: Here's Why (Zacks)
03:23PM	Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online (GuruFocus.com)
11:09AM	Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts (The Wall Street Journal)
09:40AM	Here's Why Amgen (AMGN) is a Strong Value Stock (Zacks)
09:00AM	AMGEN MAKES REPATHA AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. (PR Newswire)
08:32AM	How J&J's Innovative Medicines Segment is Poised Ahead of Q3 Results (Zacks)
Oct-04-25 06:45AM	4 Reasons to Buy Amgen Stock Right Now (Motley Fool)
Oct-03-25 11:10AM	Cramer's Stop Trading: Amgen (CNBC TV)
07:46AM	Long-term benefit of Amgens Repatha in reducing MACE shown in Phase III trial (Clinical Trials Arena)
07:46AM	Amgens Phase III data supports FDA label expansion of Repatha (Pharmaceutical Technology)
07:46AM	Amgens Phase III data cements FDA decision to expand Repatha label (Clinical Trials Arena)
Oct-02-25 09:50AM	Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term (Zacks)
09:23AM	Stock Market News for Oct 2, 2025 (Zacks)
09:00AM	Loading…
09:00AM	LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS (PR Newswire)
07:53AM	Amgen claims landmark study result that could widen heart drugs use (BioPharma Dive)
07:00AM	Bruce Beutler Unlocked Key Mystery To Disease And He's Not Done (Investor's Business Daily)
03:26AM	2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer (Motley Fool)
02:55AM	Amgen Inc (AMGN) Ramps Up Manufacturing Capacity in US, Amidst Hefty Tariffs (Insider Monkey)
02:33AM	Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion (Insider Monkey)
Oct-01-25 07:31PM	Analyst Report: Amgen Inc. (Morningstar Research) +5.78%
07:30PM	Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill Diversifies Portfolio With Bitcoin ETF, Tech Stocks (Benzinga)
04:55PM	Drug Stock Rally Helps Push Dow and S&P 500 to Records (The Wall Street Journal)
04:36PM	Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff (Investor's Business Daily)
04:00PM	Why Are Amgen (AMGN) Shares Soaring Today (StockStory)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Sep-30-25 04:47PM	Pfizer Stock Soars on Trumps New Drug Pricing Plan. Heres Why. (Barrons.com)
02:49PM	Bank of America Securities Maintains a Sell Rating on Amgen (AMGN) (Insider Monkey)
01:06PM	Pfizers Trump Deal Eases Drug Pricing, Tariff Pressure. Drug Stocks Are Up. (Barrons.com)
10:34AM	Pfizer, Other Drug Stocks Jump on Reports of Trump Pricing Plan (Barrons.com)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:46AM	Amgen to expand US drug production with $650M investment (Manufacturing Dive)
Sep-29-25 04:29AM	Amgen to invest $650m in US manufacturing network expansion (Pharmaceutical Technology)
01:39AM	Amgen Inc.'s (AMGN) and AstraZeneca's (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency (Insider Monkey)
Sep-28-25 06:43PM	Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs (Insider Monkey)
Sep-26-25 05:30PM	GLP-1 race evolves as Amgen & weight-loss pills enter the scene (Yahoo Finance Video)
04:51PM	Eli Lilly, Pfizer, Amgen Stocks Rise After Trumps 100% Pharma Tariff Threat. Heres Why. (Barrons.com)
04:40PM	All bark, no bite: Trumps latest trade war turns into another TACO salad for Wall Street (Fortune)
04:15PM	These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More (Barrons.com)
02:19PM	These Stocks Are Moving the Most Today: Eli Lilly, Intel, Paccar, GlobalFoundries, Boeing, AppLovin, Costco, and More (Barrons.com)
11:10AM	Analysts Cite Amgen's (AMGN) Strong Therapies Pipeline to Reaffirm Bullish Outlook (Insider Monkey)
10:29AM	Amgen to Invest $650 Million in U.S. Production Expansion as Trump Hikes Tariffs (The Wall Street Journal)
09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
09:00AM	AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS (PR Newswire)
08:15AM	Eli Lilly, Pfizer Stocks Rise After Trump's 100% Pharma Tariff Threat. Here's Why. (Barrons.com)
Sep-25-25 10:52PM	US, European pharma stocks steady after Trump's tariff move, Asia slips (Reuters)
11:36AM	Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks? (Insider Monkey)
Sep-24-25 05:50PM	Amgen (AMGN) Dips More Than Broader Market: What You Should Know (Zacks)
12:25PM	LLY vs. NVO: Which Obesity Drug Stock Is the Better Buy Now? (Zacks)
04:00AM	Pharmas next generation of blockbuster antibodies takes a more is better approach (Pharma Voice)
Sep-23-25 11:57AM	AZN Gets CHMP Nod for Label Expansion of Koselugo & Tezspire (Zacks)
Sep-22-25 10:37AM	Stock Market Today: Dow Up As Apple, Tesla Gain On These Calls; Oracle Pops After Executive Shuffle (Live Coverage) (Investor's Business Daily)
10:37AM	Stock Market Today: Dow Falls As Apple, Tesla Gain On These Calls; Obesity Play Rockets On Pfizer Move (Live Coverage) (Investor's Business Daily)
10:22AM	Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last? (Zacks)
09:16AM	J&J Adds $63B in Market Cap in 3 Months: Time to Buy the Stock? (Zacks)
Sep-19-25 04:09PM	Top Research Reports for Costco, Morgan Stanley & Caterpillar (Zacks)
04:05PM	Why Amgen (AMGN) Stock Is Trading Up Today (StockStory)
01:17PM	EMA Backs Amgen Drug For Rare Autoimmune Disorder (Benzinga)
Sep-18-25 11:30AM	J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why (Zacks)
Sep-17-25 09:53AM	NVO Stock Rises on Upbeat Phase III Data for Cagrilintide in Obesity (Zacks)
09:40AM	Why Amgen (AMGN) is a Top Value Stock for the Long-Term (Zacks)
02:30AM	Ollin debuts with $100M and plans to challenge top-selling eye drugs (BioPharma Dive)
Sep-16-25 02:58PM	What Do Analysts Think About Amgen Inc. (AMGN)? (Insider Monkey)
12:58PM	AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play? (Zacks)
09:09AM	Stock Market Today: Dow Wavers Amid Surprise Retail Sales; Dave & Busters Plunges (Live Coverage) (Investor's Business Daily)
Sep-15-25 03:31PM	Stock Market Today: Indexes Up As Chips Fall On China; Buffett Stock Tests Entry (Live Coverage) (Investor's Business Daily)
02:40PM	Stock Market Today: Dow Steadies, Nasdaq Up But These Chip Stocks Fall On China Move; Gold Stock Hits Entry (Live Coverage) (Investor's Business Daily)
01:44PM	Stock Market Today: Dow, Nasdaq Gain As Uber Clears Entry; Gold Stock Hits Entry (Live Coverage) (Investor's Business Daily)
11:53AM	Why Californias biopharma boom is critical for logistics (FreightWaves)
11:08AM	Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now? (Zacks)
09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:14AM	Samsung Biologics, Amgen and Biocon invest in US pharma sites (Manufacturing Dive)
Sep-14-25 07:15AM	2 Healthcare Dividend Stocks to Buy and Hold (Motley Fool)
01:17AM	Guggenheim Maintains a Hold on Amgen Inc. (AMGN) (Insider Monkey)
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Sep-11-25 12:49PM	Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab (Insider Monkey)
10:02AM	Where Does VKTX Stock Stand After the Obesity Pill Setback? (Zacks)
Sep-10-25 10:28AM	Is NVO's Major Restructuring Plan an Indication to Sell the Stock? (Zacks)
07:33AM	Kriya, Odyssey secure megarounds; Amgen boosts R&D leadership (BioPharma Dive)
Sep-09-25 03:06PM	Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis (Benzinga)
07:22AM	Amgen and Kyowa Kirin report preliminary outcomes from AD treatment trial (Clinical Trials Arena)
Sep-08-25 09:06PM	If You'd Invested $10,000 in Amgen Stock (AMGN) 3 Years Ago, Here's How Much You'd Have Today (Motley Fool)
08:04PM	AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS (PR Newswire)
07:33PM	Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	Aug 20 '25	Sale	296.99	1,267	376,280	7,209	Aug 22 07:21 PM
Grygiel Nancy A.	Officer	Aug 20 '25	Proposed Sale	294.32	1,267	372,909		Aug 20 04:31 PM
Khosla Rachna	SVP, Business Development	Jun 05 '25	Sale	289.68	1,500	434,520	8,162	Jun 06 07:49 PM
Khosla Rachna	Officer	Jun 05 '25	Proposed Sale	290.00	1,500	435,000		Jun 05 12:24 PM
Busch Matthew C.	VP, Finance & CAO	May 02 '25	Sale	279.69	1,000	279,690	4,034	May 06 08:07 PM
Busch Matthew C.	Officer	May 02 '25	Proposed Sale	281.44	1,000	281,440		May 02 02:37 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	80,257	Feb 21 08:07 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Sale	292.84	8,711	2,550,903	71,546	Feb 21 08:07 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	70,858	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 21 '25	Sale	304.44	25,225	7,679,524	36,922	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Sale	293.22	8,711	2,554,224	62,147	Feb 21 08:06 PM
DAVID M REESE & JOAN I CHUCO-T	Officer	Feb 21 '25	Proposed Sale	304.44	25,225	7,679,524		Feb 21 04:27 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Option Exercise	156.35	1,524	238,277	10,068	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Sale	293.74	1,524	447,655	8,544	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 18 '25	Sale	292.56	500	146,279	8,544	Feb 20 08:59 PM
DEREK MILLER	Officer	Feb 19 '25	Proposed Sale	293.74	1,524	447,655		Feb 19 04:18 PM
DAVID REESE	Officer	Feb 19 '25	Proposed Sale	293.22	8,711	2,554,224		Feb 19 04:14 PM
Santos Esteban	Affiliate	Feb 19 '25	Proposed Sale	292.11	8,711	2,544,570		Feb 19 02:25 PM
DEREK MILLER	Officer	Feb 18 '25	Proposed Sale	292.56	500	146,279		Feb 18 04:10 PM
Gordon Murdo	EVP, Global Commercial Ops	Feb 11 '25	Sale	294.79	8,771	2,585,644	44,186	Feb 13 09:02 PM
Gordon Murdo	Officer	Feb 11 '25	Proposed Sale	295.30	8,771	2,590,076		Feb 11 03:01 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Option Exercise	156.35	25,045	3,915,786	54,032	Feb 10 09:52 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Sale	293.12	25,045	7,341,123	28,987	Feb 10 09:52 PM
Graham Jonathan P	Officer	Feb 07 '25	Proposed Sale	292.94	25,045	7,336,682		Feb 07 03:05 PM
Grygiel Nancy A.	SVP & CCO	Feb 05 '25	Sale	304.47	1,589	483,808	7,210	Feb 06 08:54 PM
Grygiel Nancy A.	Officer	Feb 05 '25	Proposed Sale	304.47	1,589	483,800		Feb 05 12:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your FINVIZ experience